Find clinical trials for Lung Cancer in Birmingham, AL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Lung Cancer trials near Birmingham, AL, USA:
and domvanalimab in combination with zimberelimab and etrumadenant (AB928) in front-line, PD-L1 positive, metastatic non-small cell lung cancer...
Phase 2
Birmingham, Alabama, United States and 64 other locations
The purpose of this study is to assess the objective response rate (ORR) of immunotherapy-based combination therapy and to assess the safety and tole...
Phase 2
Birmingham, Alabama, United States and 23 other locations
The main aim of this study is to:evaluate safety and efficacy (per Response Evaluation Criteria in Solid Tumors version 1.1 [RECIST 1.1] by investiga...
Phase 2
Birmingham, Alabama, United States and 79 other locations
untreated for advanced or metastatic, PD-L1 positive non-small cell lung cancer (NSCLC). The primary objective is to evaluate the p...
Phase 2
Birmingham, Alabama, United States of America and 23 other locations
This study is being done to determine the efficacy and safety of cofetuzumab pelidotin in the PTK7-expressing, recurrent non-small cell lung ...
Phase 1
Birmingham, Alabama, United States and 25 other locations
survival compared with carboplatin, etoposide, and nivolumab alone in newly diagnosed participants with extensive-stage small cell lung cancer...
Phase 2
Birmingham, Alabama, United States and 42 other locations
with concomitant chemotherapy for stage III non-small cell lung cancer (NSCLC) will result in decreased acute respiratory and esoph...
Birmingham, Alabama, United States
The study is a prospective, randomized controlled phase III trial aimed to test the efficacy and safety of TTFields, using the NovoTTF-200T device, c...
Phase 3
Birmingham, Alabama, United States of America and 123 other locations
The study is a prospective, randomized controlled phase III trial, to test the efficacy, safety and neurocognitive outcomes of advanced NSCLC patient...
Phase 3
Birmingham, Alabama, United States and 127 other locations
dose (RP2D) of REGN5093 in patients with MET-altered Non-small cell lung cancer (NSCLC).The primary objective of the dose expansion...
Phase 1, Phase 2
Birmingham, Alabama, United States and 29 other locations
Clinical trials
Research sites
Resources
Legal